Xiaoyan Du

Antibodies to ILT3 abrogate myeloid immunosuppression and enable tumor killing

J. Lunceford, R. Bueno, Douglas C. Wilson, 2021, bioRxiv.

Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort.

Dermot F. Reilly, D. Reilly, T. Vogt, 2016, Journal of the American Society of Nephrology : JASN.

Antibody-drug conjugates: integrated bioanalytical and biodisposition assessments in lead optimization and selection

Yi Wei Zhang, S. Antonenko, J. Yearley, 2018, AAPS Open.